Boston Interactome, Inc.
Boston, MA
- UEI
- V9M6AKU9GBE7
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 127 Western Ave, Boston, MA 02134, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing I2H for near-complete PPI-mapping and drug discovery - abstract protein-protein interactions (ppis) are… | National Institute of General Medical Sciences | $349,753 | |
| Developing high-precision epigenetic therapeutics for opioid use disorder - abstract opioid abuse disorder (OUD) is a… | National Institute on Drug Abuse | $398,137 |
Quick answers
What is Boston Interactome, Inc.'s UEI?
Boston Interactome, Inc.'s Unique Entity ID (UEI) in SAM.gov is V9M6AKU9GBE7.
Where is Boston Interactome, Inc. located?
Boston Interactome, Inc.'s physical address in SAM.gov is 127 Western Ave, Boston, MA 02134, USA.
Is Boston Interactome, Inc. registered in SAM.gov?
Yes. Boston Interactome, Inc.'s SAM.gov registration is active through January 23, 2027.
What is Boston Interactome, Inc.'s most recent federal award?
Boston Interactome, Inc.'s most recent federal grant award is Developing I2H for near-complete PPI-mapping and drug discovery - abstract protein-protein interactions (ppis) are… (R43GM165212), from National Institute of General Medical Sciences, on September 1, 2026.
On GovTribe
See Boston Interactome, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors